Steve Seedhouse
Stock Analyst at Cantor Fitzgerald
(2.50)
# 2,241
Out of 4,955 analysts
4
Total ratings
75%
Success rate
9.44%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Steve Seedhouse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLS Apellis Pharmaceuticals | Maintains: Overweight | $39 → $40 | $27.80 | +43.88% | 1 | Aug 1, 2025 | |
| INVA Innoviva | Initiates: Overweight | $26 | $20.01 | +29.94% | 1 | Jul 11, 2025 | |
| TVRD Tvardi Therapeutics | Initiates: Overweight | $52 | $28.00 | +85.71% | 1 | Jul 11, 2025 | |
| HROW Harrow | Initiates: Overweight | $76 | $40.05 | +89.76% | 1 | Jul 11, 2025 |
Apellis Pharmaceuticals
Aug 1, 2025
Maintains: Overweight
Price Target: $39 → $40
Current: $27.80
Upside: +43.88%
Innoviva
Jul 11, 2025
Initiates: Overweight
Price Target: $26
Current: $20.01
Upside: +29.94%
Tvardi Therapeutics
Jul 11, 2025
Initiates: Overweight
Price Target: $52
Current: $28.00
Upside: +85.71%
Harrow
Jul 11, 2025
Initiates: Overweight
Price Target: $76
Current: $40.05
Upside: +89.76%